PreLiveR-T consists of a prospective randomized clinical trial conducted in an adult population that is a candidate for liver transplantation (LT) at the Hospital La Fe Valencia (Spain). The study is structured in three phases: I) Prehabilitation (2 months before LT); II) Training, divided in two successive periods: Supervised training (months 3-6 after LT) and Unsupervised training (6-12 months after LT); III) Long-term follow-up (2 years after LT). Primary outcomes are related to post-surgery evolution (morbidity and mortality, hospitalization length, etc.). As a secondary outcomes are collected those related to: functional capacity, muscle strength and quality of life.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Morbidity
Timeframe: The groups will be assessed from the hospitalization up to 24-months.
Mortality
Timeframe: The groups will be assessed from the hospitalization until the date of death, assessed up to 24-months.
Number of hospitalization days
Timeframe: The groups will be assessed during hospitalization, approximately 7 days.
Number of days with supplementary oxygen therapy and/or mechanical ventilation
Timeframe: The groups will be assessed during hospitalization, approximately 7 days.
Progression in the activities of daily life (ADL)
Timeframe: The groups will be assessed during hospitalization, approximately 7 days.